---
title: Ozenoxacin
description: >-
  Ozenoxacin is a topical antibiotic indicated for the treatment of impetigo
  caused by *Staphylococcus aureus* or *Streptococcus pyogenes*.  It is
  classified as a quinolone antibiotic. Ozenoxacin exerts its antibacterial
  effect by inhibiting bacterial DNA replication enzymes, specifically DNA
  gyras...
is_banned: false
lastModified: '2025-09-22T17:21:53.825Z'
faqs:
  - q: >-
      What is the recommended dosage for Ozenoxacin?**


      **A:**  Apply a thin layer of ozenoxacin 1% cream to the affected area
      twice daily for 5 days.
    a: >-
      A:**  Apply a thin layer of ozenoxacin 1% cream to the affected area twice
      daily for 5 days.
  - q: >-
      How does Ozenoxacin work?**


      **A:** Ozenoxacin inhibits bacterial DNA gyrase and topoisomerase IV,
      essential enzymes for bacterial DNA replication.
    a: >-
      A:** Ozenoxacin inhibits bacterial DNA gyrase and topoisomerase IV,
      essential enzymes for bacterial DNA replication.
  - q: >-
      What are the common side effects of Ozenoxacin?**


      **A:**  Common side effects are generally mild and localized to the
      application site, including itching, redness, and irritation.
    a: >-
      A:**  Common side effects are generally mild and localized to the
      application site, including itching, redness, and irritation.
  - q: >-
      Is Ozenoxacin safe to use during pregnancy?**


      **A:**  Data on ozenoxacin use during pregnancy are limited. Use with
      caution only if the potential benefit justifies the potential risk to the
      fetus.  Due to minimal systemic absorption, fetal exposure is expected to
      be low.
    a: >-
      A:**  Data on ozenoxacin use during pregnancy are limited. Use with
      caution only if the potential benefit justifies the potential risk to the
      fetus.  Due to minimal systemic absorption, fetal exposure is expected to
      be low.
  - q: >-
      Can Ozenoxacin be used in children?**


      **A:** Ozenoxacin is approved for use in children 2 months and older.  Use
      in infants under 2 months is not recommended due to a lack of safety and
      efficacy data.
    a: >-
      A:** Ozenoxacin is approved for use in children 2 months and older.  Use
      in infants under 2 months is not recommended due to a lack of safety and
      efficacy data.
  - q: >-
      What should I do if I miss a dose of Ozenoxacin?**


      **A:** If a dose is missed, apply it as soon as remembered and then
      continue with the regular dosing schedule. Do not apply extra cream to
      make up for a missed dose.
    a: >-
      A:** If a dose is missed, apply it as soon as remembered and then continue
      with the regular dosing schedule. Do not apply extra cream to make up for
      a missed dose.
  - q: >-
      How long does it take for Ozenoxacin to work?**


      **A:** Improvement is usually seen within a few days of starting
      treatment. If symptoms do not improve within 3 days, re-evaluate the
      diagnosis and consider alternative therapy.
    a: >-
      A:** Improvement is usually seen within a few days of starting treatment.
      If symptoms do not improve within 3 days, re-evaluate the diagnosis and
      consider alternative therapy.
  - q: >-
      Can Ozenoxacin be used for other skin infections besides impetigo?**


      **A:** Ozenoxacin is specifically indicated for the treatment of impetigo.
      It is not recommended for other skin infections unless directed by a
      healthcare professional.
    a: >-
      A:** Ozenoxacin is specifically indicated for the treatment of impetigo.
      It is not recommended for other skin infections unless directed by a
      healthcare professional.
  - q: |-
      Are there any drug interactions with Ozenoxacin?**

      **A:** No clinically significant drug interactions have been identified.
    a: 'A:** No clinically significant drug interactions have been identified.'
  - q: >-
      What should I do if my impetigo doesn't improve with Ozenoxacin?**


      **A:**  Consult a physician if your condition doesn't improve after 3 days
      of treatment or if it worsens.  An alternative therapy may be necessary.
    a: >-
      A:**  Consult a physician if your condition doesn't improve after 3 days
      of treatment or if it worsens.  An alternative therapy may be necessary.
---
## **Usage**

Ozenoxacin is a topical antibiotic indicated for the treatment of impetigo caused by *Staphylococcus aureus* or *Streptococcus pyogenes*.  It is classified as a quinolone antibiotic. Ozenoxacin exerts its antibacterial effect by inhibiting bacterial DNA replication enzymes, specifically DNA gyrase and topoisomerase IV. This dual-target mechanism disrupts bacterial DNA synthesis, leading to bacterial cell death.

## **Alternate Names**

Ozenoxacin is the generic name. A recognized brand name is Xepi.  There are no widely used alternate names or regional variations.

## **How It Works**

**Pharmacodynamics:** Ozenoxacin inhibits bacterial DNA replication by binding to both DNA gyrase and topoisomerase IV. This dual action leads to bacterial cell death. The cream formulation is for topical application only.

**Pharmacokinetics:**  Following topical administration, systemic absorption of ozenoxacin is negligible.  Due to the minimal systemic exposure, information regarding metabolism and elimination pathways is limited. Available studies suggest that ozenoxacin is moderately protein-bound in plasma (approximately 85-87%).  As systemic absorption is minimal, hepatic and renal impairment are not expected to significantly impact ozenoxacin's pharmacokinetic profile.

**Mode of Action:**  Ozenoxacin's antibacterial action is mediated through inhibition of the bacterial enzymes DNA gyrase and topoisomerase IV.  These enzymes are crucial for bacterial DNA replication and repair.  By binding to both targets, ozenoxacin effectively blocks bacterial DNA synthesis, halting bacterial growth and leading to cell death.

## **Dosage**

### **Standard Dosage**

#### **Adults:** Apply a thin layer of ozenoxacin 1% cream to the affected skin area twice daily (every 12 hours) for 5 days. The maximum treatment area should not exceed 100 cm².

#### **Children:**

* **2 months and older:** Apply a thin layer of ozenoxacin 1% cream to the affected skin area twice daily (every 12 hours) for 5 days.  For children under 12 years of age, the maximum treatment area should not exceed 2% of the total body surface area and should not exceed 100 cm².
* **Under 2 months:** Safety and efficacy have not been established.


#### **Special Cases:**

* **Elderly Patients:** No dosage adjustment is necessary.
* **Patients with Renal Impairment:** No dosage adjustment is necessary.
* **Patients with Hepatic Dysfunction:** No dosage adjustment is necessary.
* **Patients with Comorbid Conditions:**  No specific dosage adjustments are indicated, but clinical judgment is advised.


### **Clinical Use Cases**

The use of ozenoxacin is limited to the topical treatment of impetigo. Its dosage and administration remain consistent across various clinical settings.  Ozenoxacin is not indicated for systemic use and therefore not relevant to scenarios like intubation, surgical procedures, mechanical ventilation, ICU use, or emergency situations.

### **Dosage Adjustments**

No dosage adjustments are typically necessary for elderly patients or those with renal or hepatic impairment.

## **Side Effects**

### **Common Side Effects**

Application site reactions, such as itching, redness, or irritation, may occur.

### **Rare but Serious Side Effects**

Severe allergic reactions (e.g., anaphylaxis) are rare.

### **Long-Term Effects**

Prolonged use may lead to overgrowth of non-susceptible organisms, including fungi.

### **Adverse Drug Reactions (ADR)**

Contact dermatitis has been reported.

## **Contraindications**

Hypersensitivity to ozenoxacin or any component of the formulation is a contraindication.

## **Drug Interactions**

No clinically significant drug interactions have been identified. *In vitro* studies suggest weak inhibition of CYP3A4 and 2C9 at high concentrations, but clinical relevance is unclear.


## **Pregnancy and Breastfeeding**

* **Pregnancy:** No adequate and well-controlled studies in pregnant women. Use only if clearly needed.  Systemic absorption is negligible, minimizing the risk of fetal exposure.
* **Breastfeeding:**  No data available on presence in human milk. Systemic absorption is negligible, minimizing the risk of infant exposure.  If used during breastfeeding, avoid application to the breast area.

## **Drug Profile Summary**

* **Mechanism of Action:** Inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication.
* **Side Effects:** Itching, redness, irritation at the application site; rarely, allergic reactions.
* **Contraindications:** Hypersensitivity to ozenoxacin.
* **Drug Interactions:** No clinically significant interactions identified.
* **Pregnancy & Breastfeeding:** Limited data; use with caution. Negligible systemic absorption minimizes fetal/infant exposure.
* **Dosage:** Apply a thin layer twice daily for 5 days.
* **Monitoring Parameters:**  Monitor the affected area for signs of improvement or adverse reactions.

## **Popular Combinations**

Ozenoxacin is typically used as monotherapy. No established combination therapies are recommended.

## **Precautions**

* **General Precautions:** For external use only. Avoid contact with eyes, mucous membranes, and open wounds.
* **Specific Populations:**
    * **Pregnant Women:**  Use with caution only if clearly needed.
    * **Breastfeeding Mothers:**  Use with caution; avoid application to the breast area.
    * **Children & Elderly:**  Dosage adjustments are generally not necessary.

## **FAQs (Frequently Asked Questions)**

### **Q1: What is the recommended dosage for Ozenoxacin?**

**A:**  Apply a thin layer of ozenoxacin 1% cream to the affected area twice daily for 5 days.


### **Q2: How does Ozenoxacin work?**

**A:** Ozenoxacin inhibits bacterial DNA gyrase and topoisomerase IV, essential enzymes for bacterial DNA replication.


### **Q3: What are the common side effects of Ozenoxacin?**

**A:**  Common side effects are generally mild and localized to the application site, including itching, redness, and irritation.


### **Q4: Is Ozenoxacin safe to use during pregnancy?**

**A:**  Data on ozenoxacin use during pregnancy are limited. Use with caution only if the potential benefit justifies the potential risk to the fetus.  Due to minimal systemic absorption, fetal exposure is expected to be low.


### **Q5: Can Ozenoxacin be used in children?**

**A:** Ozenoxacin is approved for use in children 2 months and older.  Use in infants under 2 months is not recommended due to a lack of safety and efficacy data.


### **Q6: What should I do if I miss a dose of Ozenoxacin?**

**A:** If a dose is missed, apply it as soon as remembered and then continue with the regular dosing schedule. Do not apply extra cream to make up for a missed dose.

### **Q7: How long does it take for Ozenoxacin to work?**

**A:** Improvement is usually seen within a few days of starting treatment. If symptoms do not improve within 3 days, re-evaluate the diagnosis and consider alternative therapy.

### **Q8: Can Ozenoxacin be used for other skin infections besides impetigo?**

**A:** Ozenoxacin is specifically indicated for the treatment of impetigo. It is not recommended for other skin infections unless directed by a healthcare professional.

### **Q9: Are there any drug interactions with Ozenoxacin?**

**A:** No clinically significant drug interactions have been identified.


### **Q10: What should I do if my impetigo doesn't improve with Ozenoxacin?**

**A:**  Consult a physician if your condition doesn't improve after 3 days of treatment or if it worsens.  An alternative therapy may be necessary.
